Literature DB >> 27181408

Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study.

N Benito1, M Franco2, A Ribera3, A Soriano4, D Rodriguez-Pardo5, L Sorlí6, G Fresco7, M Fernández-Sampedro8, M Dolores Del Toro9, L Guío10, E Sánchez-Rivas11, A Bahamonde12, M Riera13, J Esteban14, J M Baraia-Etxaburu15, J Martínez-Alvarez16, A Jover-Sáenz17, C Dueñas18, A Ramos19, B Sobrino20, G Euba3, L Morata4, C Pigrau5, P Coll21, I Mur22, J Ariza3.   

Abstract

It is important to know the spectrum of the microbial aetiology of prosthetic joint infections (PJIs) to guide empiric treatment and establish antimicrobial prophylaxis in joint replacements. There are no available data based on large contemporary patient cohorts. We sought to characterize the causative pathogens of PJIs and to evaluate trends in the microbial aetiology. We hypothesized that the frequency of antimicrobial-resistant organisms in PJIs has increased in the recent years. We performed a cohort study in 19 hospitals in Spain, from 2003 to 2012. For each 2-year period (2003-2004 to 2011-2012), the incidence of microorganisms causing PJIs and multidrug-resistant bacteria was assessed. Temporal trends over the study period were evaluated. We included 2524 consecutive adult patients with a diagnosis of PJI. A microbiological diagnosis was obtained for 2288 cases (90.6%). Staphylococci were the most common cause of infection (1492, 65.2%). However, a statistically significant rising linear trend was observed for the proportion of infections caused by Gram-negative bacilli, mainly due to the increase in the last 2-year period (25% in 2003-2004, 33.3% in 2011-2012; p 0.024 for trend). No particular species contributed disproportionally to this overall increase. The percentage of multidrug-resistant bacteria PJIs increased from 9.3% in 2003-2004 to 15.8% in 2011-2012 (p 0.008), mainly because of the significant rise in multidrug-resistant Gram-negative bacilli (from 5.3% in 2003-2004 to 8.2% in 2011-2012; p 0.032). The observed trends have important implications for the management of PJIs and prophylaxis in joint replacements.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Microbial aetiology; Microbiology; Multidrug-resistant organisms; Prosthetic joint infection; Surgical site infection

Mesh:

Substances:

Year:  2016        PMID: 27181408     DOI: 10.1016/j.cmi.2016.05.004

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  42 in total

1.  CORR Insights®: Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.

Authors:  Alex Soriano
Journal:  Clin Orthop Relat Res       Date:  2017-04-18       Impact factor: 4.176

2.  Evaluation of the use of sonication of retrieved implants for the diagnosis of prosthetic joint infection in a routine setting.

Authors:  Laura Prieto-Borja; Álvaro Auñón; Antonio Blanco; Ricardo Fernández-Roblas; Ignacio Gadea; Joaquín García-Cañete; Raúl Parrón; Jaime Esteban
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-21       Impact factor: 3.267

3.  Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Authors:  L Morata; J Cobo; M Fernández-Sampedro; P Guisado Vasco; E Ruano; J Lora-Tamayo; M Sánchez Somolinos; P González Ruano; A Rico Nieto; A Arnaiz; M Estébanez Muñoz; M E Jiménez-Mejías; A B Lozano Serrano; E Múñez; D Rodriguez-Pardo; R Argelich; A Arroyo; J M Barbero; F Cuadra; A Del Arco; M D Del Toro; L Guio; D Jimenez-Beatty; N Lois; O Martin; R M Martínez Alvarez; F J Martinez-Marcos; L Porras; M Ramírez; J Vergas García; A Soriano
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

4.  Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  Anna Aguilar-Colomer; Juan Carlos Doadrio; Concepción Pérez-Jorge; Miguel Manzano; Maria Vallet-Regí; Jaime Esteban
Journal:  J Antibiot (Tokyo)       Date:  2016-12-21       Impact factor: 2.649

5.  Antibiotic release from F-doped nanotubular oxide layer on TI6AL4V alloy to decrease bacterial viability.

Authors:  John-Jairo Aguilera-Correa; Antonio L Doadrio; Ana Conde; Maria-Angeles Arenas; Juan-Jose de-Damborenea; María Vallet-Regí; Jaime Esteban
Journal:  J Mater Sci Mater Med       Date:  2018-07-20       Impact factor: 3.896

Review 6.  Risk Factors and Treatment Options for Failure of a Two-Stage Exchange.

Authors:  Lorenzo Fagotti; Jakub Tatka; Mauro Jose Costa Salles; Marcelo C Queiroz
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

7.  Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets.

Authors:  John M Thompson; Robert J Miller; Alyssa G Ashbaugh; Carly A Dillen; Julie E Pickett; Yu Wang; Roger V Ortines; Robert S Sterling; Kevin P Francis; Nicholas M Bernthal; Taylor S Cohen; Christine Tkaczyk; Li Yu; C Kendall Stover; Antonio DiGiandomenico; Bret R Sellman; Daniel Lj Thorek; Lloyd S Miller
Journal:  JCI Insight       Date:  2018-09-06

8.  Microbiological and Cellular Evaluation of a Fluorine-Phosphorus-Doped Titanium Alloy, a Novel Antibacterial and Osteostimulatory Biomaterial with Potential Applications in Orthopedic Surgery.

Authors:  John-Jairo Aguilera-Correa; Aranzazu Mediero; Francisco-Miguel Conesa-Buendía; Ana Conde; María-Ángeles Arenas; Juan-José de-Damborenea; Jaime Esteban
Journal:  Appl Environ Microbiol       Date:  2019-01-09       Impact factor: 4.792

9.  [Research progress of two-stage revision for periprosthetic joint infection after hip and knee arthroplasties].

Authors:  Xiangxuan Wang; Wenming Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-12-15

10.  Synovial Fluid Mediated Aggregation of Clinical Strains of Four Enterobacterial Species.

Authors:  Alicia Macias-Valcayo; Amelia Staats; John-Jairo Aguilera-Correa; Jack Brooks; Tripti Gupta; Devendra Dusane; Paul Stoodley; Jaime Esteban
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.